News
2d
Live Science on MSNDrug slashes migraine days by half in early trial — and it may work with completely 'new mechanism'The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the ...
Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...
This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.
A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.
A drug commonly used to treat type 2 diabetes may reduce excess fluid in the brains of patients with hydrocephalus, which ...
A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.
19h
News-Medical.Net on MSNNewer, more effective diabetes drugs reach only a fraction of patientsA UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...
A stem cell-based treatment may have cured 10 out of 12 patients with the most severe form of type 1 diabetes -- during a ...
2d
Health and Me on MSNNew ‘Exercise In A Pill’ Could Outperform Ozempic Without The Muscle LossA new oral drug mimics exercise, burns fat, lowers blood sugar, and preserves muscle mass, potentially outperforming Ozempic ...
A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new ...
People with type 1 diabetes who need to lose weight can benefit from the blockbuster GLP-1 drug semaglutide currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results